Concepedia

Author

Nicola M. Spirtos

Women's Cancer Center of Nevada

Also Known As

N. M. Spirtos, N. Spirtos, N.M. Spirtos, Nicola M. Spirtos, Nicola Spirtos

24

Publications

1.2K

Citations

11

H-Index

26

Concepts

All Affiliations

Women's Cancer Center of NevadaThe University of Texas Southwestern Medical CenterGynecologic Oncology GroupProvidence CollegeUniversity of Oklahoma
NM

About

Nicola M. Spirtos is an author at Women's Cancer Center of Nevada specializing in medicine, gynecology oncology, and obstetrics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

895

2

Obstetrics

6

6

528

3

Public Health

2

2

233

4

Pathology

2

2

437

5

Health Sciences

1

1

367

Nicola M. Spirtos

×

11

Publications

1.2K

Citations

11

H-Index

YearCitations

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

Robert L. Coleman, Domenica Lorusso, Christine Gennigens,

The Lancet Oncology

2021

367

Radical trachelectomy and pelvic lymphadenectomy with uterine preservation in the treatment of cervical cancer

John B. Schlaerth, Nicola M. Spirtos, Alan C. Schlaerth

American Journal of Obstetrics and Gynecology

2003

196

Phase III Randomized Trial of Weekly Cisplatin and Irradiation Versus Cisplatin and Tirapazamine and Irradiation in Stages IB2, IIA, IIB, IIIB, and IVA Cervical Carcinoma Limited to the Pelvis: A Gynecologic Oncology Group Study

Paul DiSilvestro, Shamshad Ali, Peter Craighead,

Journal of Clinical Oncology

2014

123

Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II

Maaike H.M. Oonk, Brian M. Slomovitz, Peter Baldwin,

Journal of Clinical Oncology

2021

114

Laparoscopic Retroperitoneal Lymphadenectomy Followed by Immediate Laparotomy in Women with Cervical Cancer: A Gynecologic Oncology Group Study

John B. Schlaerth, Nicola M. Spirtos, Linda F. Carson,

Gynecologic Oncology

2002

102

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley,

The Lancet Oncology

2019

85

A randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel vs. carboplatin and paclitaxel for optimally debulked, advanced endometrial carcinoma.

Daniela Matei, Virginia L. Filiaci, Marcus E. Randall,

Journal of Clinical Oncology

2017

70

Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis

Kimberly Levinson, Anna Beavis, Christopher Purdy,

Gynecologic Oncology

2021

58

A Phase 3 Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High-Risk, Early-Stage Endometrial Cancer: A Gynecology Oncology Group Study

Marcus E. Randall, Virginia L. Filiaci, D. Scott McMeekin,

International Journal of Radiation Oncology*Biology*Physics

2017

38

A randomized phase 3 trial of paclitaxel (P) plus carboplatin (C) versus paclitaxel plus ifosfamide (I) in chemotherapy-naive patients with stage I-IV, persistent or recurrent carcinosarcoma of the uterus or ovary: An NRG Oncology trial.

Matthew A. Powell, Virginia L. Filiaci, Martee L. Hensley,

Journal of Clinical Oncology

2019

37

Page 1